Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Feb 2026 for Organogenesis Holdings Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jon L. Giacomin: trading record in brief
Jon L. Giacomin, listed as board member, appears in our data through filings on Organogenesis Holdings Inc. shares, published by SEC (Form 4). Over a trading history stretching from 7 May 2021 to 18 February 2026, the count stands at 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 20 February 2026: a share grant, in Organogenesis Holdings Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jon L. Giacomin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
48,828 shares0Class A Common StockSEC:0002064832-26-000055:0
49,575 shares0Class A Common StockSEC:0001062993-25-003210:0
51,020 shares0Class A Common StockSEC:0001062993-24-004305:0
65,737 shares0Class A Common StockSEC:0001062993-23-004882:0
20,547 shares0Class A Common StockSEC:0001062993-22-004808:0
5,319 shares0Class A Common StockSEC:0001661181-21-000044:0
6 of 6 declarations
